| Sign In to gain access to subscriptions and/or personal tools. |
Multiple Sclerosis, Vol. 14, No. 3, 415-417 (2008) DOI: 10.1177/1352458507083444 © 2008 SAGE Publications Uveitis associated with multiple sclerosisDepartment of Internal Medicine, Hospices Civils de Lyon, Hotel Dieu, 1 place de l'Hôpital, 69288 Lyon Cedex 02, France and University Claude Bernard Lyon 1, Lyon, France
Department of Internal Medicine, Hospices Civils de Lyon, Hotel Dieu, 1 place de l'Hôpital, 69288 Lyon Cedex 02, France and University Claude Bernard Lyon 1, Lyon, France, pascal.seve{at}chu-lyon.fr
Department of Neurology A and EDMUS Coordinating Center, Hôpital Neurologique, Hospices Civils de Lyon, Lyon, France, Université Lyon 1, Lyon, France, INSERM U842, Lyon, France
Department of Internal Medicine, Hospices Civils de Lyon, Hotel Dieu, 1 place de l'Hôpital, 69288 Lyon Cedex 02, France and University Claude Bernard Lyon 1, Lyon, France
Department of Neurology A and EDMUS Coordinating Center, Hôpital Neurologique, Hospices Civils de Lyon, Lyon, France, Université Lyon 1, Lyon, France, INSERM U842, Lyon, France
Department of Neurology A and EDMUS Coordinating Center, Hôpital Neurologique, Hospices Civils de Lyon, Lyon, France, Université Lyon 1, Lyon, France, INSERM U842, Lyon, France Our study aimed to determine the frequency of uveitis among MS patients through the Lyon MS Database and compare the clinical spectrum and time course of MS in patients with or without uveitis. Twenty-eight patients with uveitis were detected. The prevalence of uveitis in our population was 0.65% (28/4300). Uveitis preceded onset of MS in 46% of the patients; it occurred simultaneously or after MS, in 18% and 36% of the cases, respectively. The topography and timing of uveitis were not associated with any significant difference in MS course and prognosis. There was no difference in the course and prognosis in patients with or without uveitis. Multiple Sclerosis 2008; 14: 415—417. http://msj.sagepub.com
Key Words: multiple sclerosis uveitis
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||